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1. Introduction 
Blood vessels are essential for embryonic development and tissue homeostasis in adults 
(Coultas et al., 2005). They supply oxygen and nutrients and remove metabolic waste from 
tissues. Blood vessels also participate in intercellular communication. Secretion of 
growth/differentiation factors by blood vessels is essential for liver and pancreas 
organogenesis (Matsumoto et al., 2001; Lammert et al., 2001). Additionally, developing 
sympathetic neurons are guided by endothelins secreted by blood vessels (Makita et al., 
2008), and liver regeneration in adults is triggered by factors secreted by liver sinusoidal 
endothelial cells (Ding et al., 2010). 
In mice, vascular progenitor cells first develop in the posterior primitive streak in response 
to fibroblast growth factor-2 (FGF-2) and bone morphogenetic protein 4 (BMP4), and they 
are marked as vascular endothelial growth factor receptor 2 (VEGFR2)positive mesodermal 
cells (Fig. 1; Park et al., 2004; Flamme et al., 1995). These precursor cells are committed for 
development into the hematopoietic and/or vascular lineage (hemangioblasts or 
angioblasts), and they migrate into extra-embryonic sites including the yolk sac and 
allantois, as well as into intra-embryonic sites (Huber et al., 2004; Hiratsuka et al., 2005). In 
the yolk sac, these progenitors aggregate and form clusters known as blood islands. The 
outer cells of the blood islands differentiate into endothelial cells, whereas the inner cells 
give rise to hematopoietic progenitor cells. These cells subsequently form primary capillary 
plexuses (vasculogenesis). In contrast, intra-embryonic angioblasts do not form a plexus 
intermediately and directly assembles into the dorsal aorta or cardinal vein. The extra-
embryonic primary capillary plexuses then fuse with the intra-embryonic vessels to form a 
complete vascular network (angiogenesis). Angiopoietins and Tie receptors, along with 
vascular endothelial growth factor-A (VEGF-A) and Notch, are involved in this process 
(Thurston et al., 2003). Finally, mural cells that have differentiated in response to 
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transforming growth factor- (TGF-) are recruited to nascent vessels by platelet-derived 
growth factor (PDGF) secreted by endothelial cells (Betsholtz et al., 2005; Lebrin et al., 2005). 
This entire process ultimately leads to mature blood vessel formation. 
 
 
Fig. 1. Blood vessel formation during mouse development. EXE, extra-embryonic ectoderm; 
INE, intra-embryonic ectoderm; PPS, posterior primitive streak 
A number of extracellular signaling molecules are involved in vascular development, some 
of which, including FGF-2, angiopoietins, PDGF, and VEGF-A, transmit their signals 
through receptor tyrosine kinases (RTKs). Signal transduction pathways downstream of 
RTKs have been extensively studied, and most share downstream effector components such 
as the Ras-mitogenactivated kinase (Ras-MAPK) and the phosphatidylinositol-3’ kinase 
(PI3K) pathways. Intriguingly, these RTKs still transmit distinct signals and play unique 
roles that drive vascular development. The molecular basis for the observed signaling 
specificity remains unclear. To better understand this important process, we focused on 
signaling downstream of VEGFR2, a functional receptor for VEGF-A, using embryonic stem 
cellderived VEGFR2+ vascular progenitor cells (Suzuki et al., 2005; Kawasaki et al., 2008; 
Sase et al., 2009). VEGFR2-null mice demonstrate severe defects in vasculogenesis, and 
VEGFR2 signaling is thought to play crucial roles in embryonic blood vessel formation 
(Shalaby et al., 1995; Shalaby et al., 1997; see below for details). 
2. Use of differentiating embryonic stem cells for the study of lineage 
specification 
To elucidate the signaling pathways important for the endothelial differentiation of vascular 
progenitor cells, we employed an in vitro vascular differentiation system using mouse 
embryonic stem cells (ESC) (Hirashima et al., 1999; Yamashita et al., 2000). In vivo, vascular 
progenitor cells must migrate to the correct microenvironment where they receive a cue for 
endothelial specification and further proliferate. It is challenging to identify the 
contributions of distinct signaling pathways to each in vivo event that occurs during vascular 
development, but the use of the in vitro system has allowed us to focus on the signaling 
www.intechopen.com
Dissecting the Signal Transduction Pathway that Directs Endothelial  
Differentiation Using Embryonic Stem Cell-Derived Vascular Progenitor Cells 247 
events required for endothelial specification by providing well-defined supplements to the 
culture medium.  
We used ESC-derived vascular progenitor cells because it is practically impossible to 
prepare a sufficient amount of vascular progenitor cells from mouse embryos for 
biochemical study. In this in vitro system, ESCs are differentiated by culture on type IV-
collagencoated dishes in the absence of leukemia inhibitory factor (LIF) for four days, and 
during this time, mesodermal cells expressing VEGFR2 are induced. VEGFR2+ cells 
(comprising 510% of the total cell population) are then sorted by magnetic-activated cell 
sorting (MACS) and used as vascular progenitors. These cells differentiate into -smooth 
muscle actin-positive (SMA+) mural cells resembling vascular smooth muscle cells in the 
presence of PDGF-BB or serum, whereas they differentiate into platelet-endothelial adhesion 
molecule 1-positive (PECAM1+) endothelial cells in response to VEGF-A (Fig. 2; Yamashita 
et al., 2000; Ema et al., 2003; Watabe et al., 2003). Alteration of the differentiation fate of 
vascular progenitor cells was also examined by limiting dilution assay. VEGFR2+ cells were 
seeded at low density (90120 cells/cm2) and allowed to form single-cellderived colonies 
for four days. After immunostaining, the numbers of PECAM1+ or SMA+ colonies, which 
reflect the fate of differentiation, were counted. In the presence of VEGF-A, endothelial 
differentiation occurs at the expense of mural differentiation: stimulation with VEGF-A 
increases PECAM1+ colonies and decreases SMA+ colonies, while the total number of 
colonies remains constant. Thus, VEGF-A stimulation alters the differentiation fate of 
vascular progenitor cells. 
 
 
Fig. 2. In vitro vascular differentiation system (Yamashita et al., 2000) 
This in vitro system was originally established using CCE embryonic stem cells. However, 
we used MGZ-5 cells and MGZRTcH cells because they are more amenable to transgene 
expression. Accordingly, we first studied MGZ-5 cells expressing genes contained in the 
pCAGIP vector (Fujikura et al., 2002). MGZ-5 cells express polyoma large T antigen, and this 
allows the efficient episomal propagation of plasmids with a polyoma origin of replication 
such as pCAGIP. Thus, transgenes contained within the pCAGIP vector are stably expressed 
in MGZ-5 cells (supertransfection method, Gassmann et al., 1996). In later experiments, we 
used MGZRTcH cells derived from MGZ-5 cells (Masui et al., 2005) in which a target gene 
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can be knocked into the ROSA26 locus by homologous recombination using the Cre-loxP 
system, and gene expression is under the control of tetracycline (Tc) (tet-off system, Masui et 
al., 2005). Importantly, the ROSA26 locus is minimally affected by epigenetic silencing 
during cell differentiation (Zamobrowicz et al., 1997). Therefore, expression of a transgene 
knocked into this locus can be regulated by Tc during nearly any stage of differentiation. 
Using this in vitro system, we have successfully pursued two different lines of investigation 
of vasculogenesis: examination of downstream effectors of VEGFR2 signaling (Section 3) 
and screening of pharmacological inhibitors (Section 4). 
3. VEGFR2 transmits unique signals to induce endothelial differentiation 
VEGFR2, also known as Flk1 in mice and KDR in human, is a member of the VEGFR family 
of RTKs, which contains three members, VEGFGR1-3 (Fig. 3; Shibuya & ClaessonWelsh, 
2006). VEGFRs share characteristic structural features: they are composed of seven 
extracellular immunoglobulin-like domains, a transmembrane region, and an intracellular 
region with intrinsic tyrosine kinase activity. They have distinct expression profiles and 
different ligand specificities among VEGF family members.  
VEGFR1, also called Flt-1 (fms-like tyrosine kinase 1) is expressed in vascular endothelial 
cells, hematopoietic stem cells, macrophages, and monocytes. VEGFR2 is expressed in both 
vascular and lymphatic endothelial cells. VEGFR3, also called Flt-4 (fms-like tyrosine kinase 
4), is principally expressed in lymphatic endothelial cells. 
 
 
Fig. 3. VEGFR family members and their cognate ligands. The tyrosine kinase domains of 
VEGFRs are separated by the “kinase insert” of ~60 amino acid residues, a structural feature 
common to PDGF receptors and FGF receptors. The fifth immunoglobulin-like domain of 
VEGFR3 has an internal cleavage. The resultant N-terminal and C-terminal polypeptides are 
linked together by a disulfide bond. 
VEGF family members, including VEGF-A, -B, -C, -D and placenta growth factor (PlGF), 
regulate the development, growth and function of vascular as well as lymphatic endothelial 
cells (Ferrara et al., 2003). VEGF-A is bound by VEGFR2 and VEGFR1, which transmit 
signals essential for vasculogenesis and angiogenesis. VEGF-C and VEGF-D are bound by 
VEGFR2 and VEGFR3 and are both involved in lymphangiogenesis (Karkkainen et al., 2004; 
Baldwin et al., 2005). PlGF and VEGF-B signal through VEGFR1, and they contribute to 
pathological angiogenesis (Carmeliet et al., 2001; Mould et al., 2003) and endothelial fatty 
acid uptake (Hagberg et al., 2010). 
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3.1 Essential role of VEGFR2 during vasculogenesis 
Individual knock-out mice lacking VEGFR1, VEGFR2, or VEGFR3 all demonstrate vascular 
defects. VEGFR1-deficient mice exhibit disorganized vasculature secondary to endothelial 
cell overgrowth (Fong et al., 1995). VEGFR3 knockout mice have defects in vascular 
remodeling and develop fluid accumulations in the pericardial sac (Dumont et al., 1998). 
Blood vessel formation occurs in VEGFR1-/- and VEGFR3-/- mice. VEGFR1 and VEGFR3 are 
thus indispensable for angiogenesis but not vasculogenesis. In contrast, VEGFR2 plays 
essential roles during vasculogenesis. It is first expressed in the vascular progenitor cells at 
the posterior primitive streak. VEGFR2-deficient mice die in utero between 8.5 and 9.5 d.p.c. 
due to lack of organized blood vessels and hematopoietic cells. VEGFR2 signaling is 
required for the formation of blood islands at extraembryonic sites (Shalaby et al., 1995), 
where vascular endothelial cells and hematopoietic cells differentiate to form primary 
plexuses. In the absence of VEGFR2 signaling, vascular progenitor cells fail to migrate to 
extraembryonic sites from the posterior primitive streak (Shalaby et al., 1997). In the embryo 
proper, VEGFR2 signaling is required for endothelial specification of the vascular progenitor 
cells (Shalaby et al., 1997). Potential endothelial precursor cells are located at the correct 
anatomical niche, but they fail to complete the differentiation pathway. The identified roles 
of VEGFR2 signaling in vascular development in vivo include promoting the proliferation, 
migration, and differentiation of progenitor cells. Additionally, VEGF-A+/- mice have 
defects in vascular development (Carmeliet te a., 1996; Ferrara et al., 1996), but VEGF-C-/- 
mice and VEGF-D-/- mice exhibit lymphatic defects (Karkkainen et al., 2004; Baldwin et al., 
2005). Therefore, the VEGF-A/VEGFR2 axis appears to be essential for vasculogenesis.  
Because VEGFR2+ mesodermal cells can give rise to lineages other than endothelial and 
hematopoietic cells, including vascular mural cells, skeletal muscle cells, and 
cardiomyocytes (Motoike et al., 2003; Ema et al., 2006), differentiation of VEGFR2+ cells 
should be appropriately specified. We examined the nature of this unique and specific 
signaling.  
3.2 VEGFR2, but not VEGFR3, directs endothelial differentiation 
Although VEGFRs differ in their ligand-binding properties, their intracellular domains 
share structural similarities. However, the signaling properties of VEGFRs remain 
incompletely understood.  
VEGF-A, which initiates signaling from both VEGFR1 and VEGFR2, promotes the 
differentiation of endothelial cells from ESC-derived VEGFR2+ cells, whereas PlGF, a 
specific ligand for VEGFR1, fails to induce endothelial differentiation despite VEGFR1 
expression by precursor cells (Yamashita et al., 2000). Thus, VEGFR1 signaling does not 
direct endothelial differentiation. We then examined the ability of VEGFR3 to induce 
endothelial differentiation (Suzuki et al., 2005). While VEGFR3 is not expressed by VEGFR2+ 
vascular progenitor cells, we ectopically expressed VEGFR3 to examine whether VEGFR3 
signaling induces endothelial cell differentiation.  
3.2.1 VEGFR3 fails to induce endothelial differentiation 
VEGFR3 cDNA was introduced into MGZ-5 ES cells using the supertransfection technique 
followed by drug selection (Gassmann et al., 1996). VEGFR2+ vascular progenitor cells were 
then collected from the transfected cells after in vitro differentiation (Suzuki et al., 2005). 
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These cells differentiated into PECAM1+ endothelial cells in response to VEGF-C 
stimulation. Although VEGF-C is bound by both VEGFR2 and VEGFR3, it does not promote 
endothelial differentiation through endogenous VEGFR2 signaling, because it failed to 
induce endothelial differentiation of mock-transfected cells. We next examined the effect of 
VEGF-C(C152S), a mutant that selectively stimulates VEGFR3 (Kirkin et al., 2001). This 
mutant did not induce endothelial differentiation, but it caused vascular progenitor cell 
differentiation into mural cells (Suzuki et al., 2005). Thus, VEGFR3 signaling alone is not 
sufficient to induce endothelial differentiation. It remains possible that VEGF-C induces 
endothelial differentiation through heterodimer formation between ectopic VEGFR3 and 
endogenous VEGFR2 in these experimental conditions. Collectively, these findings indicate 
that VEGFR2 has unique properties among VEGFR family members even in this in vitro 
system.  
3.2.2 The intracellular domain of VEGFR2 can transmit signals for endothelial 
differentiation 
We next examined the intracellular events downstream of VEGFR2 that are required for 
endothelial differentiation. For this purpose, we constructed a chimeric receptor (denoted 
R32) that is composed of the extracellular and the transmembrane domains of VEGFR3 
fused with the intracellular domain of VEGFR2 (Fig. 4; Sase et al., 2009).  We then 
established ES cell lines expressing either R32 or VEGFR3 under the control of the Tc-
regulated promoter in MGZRTcH cells (denoted Tc-R32 and Tc-VEGFR3, respectively). 
  
 
Fig. 4. Schematic structure of the chimeric receptor R32  
VEGFR2+ vascular progenitor cells prepared from these cell lines differentiated into 
PECAM1+ cells following VEGF-A stimulation, indicating that these cell lines retain their 
ability to differentiate into endothelial cells. However, VEGFR2+ cells derived from Tc-R32, 
but not Tc-VEGFR3, differentiated into PECAM1+ cells upon stimulation with VEGF-
C(C152S). The PECAM1+ cells were also positive for other endothelial markers (VE-
cadherin, CD34, and endoglin) and appeared to be endothelial cells. Therefore, the 
differences in phenotypes between VEGFR2+ cells derived from Tc-R32 and Tc-VEGFR3 
cells are due to intrinsic properties of the intracellular domains of VEGFR2 and VEGFR3. 
The intracellular domain of VEGFR2 is sufficient to direct endothelial differentiation of ESC-
derived vascular progenitor cells. 
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3.2.3 Tyrosine 1175 of human VEGFR2 is required for endothelial specification of 
vascular progenitor cells and endothelial cell survival 
The role of signal transduction pathways downstream of VEGFR2 for cell proliferation, 
migration and survival have been well explored in mature endothelial cells. Five tyrosine 
residues (Y951, Y1054, Y1059, Y1175, and Y1214) have been identified in the intracellular 
domain of VEGFR2 as major phosphorylation sites (Matsumoto et al., 2005). Y1054 and Y1059 
are located in the activation loop of the kinase domain and are required for the activation of 
intrinsic kinase activity. The remaining tyrosine residues are located outside of the kinase 
domain and are required for recruitment of downstream effectors. Phosphorylation of Y1175 
leads to phospholipase C-activation, followed by protein kinase C (PKC) -mediated Raf 
activation to induce cell proliferation (Takahashi et al., 2000). Y1175 is also involved in the 
activation of the PI3 kinase pathway through the adaptor protein Shb (Welch et al., 1994). In 
contrast, phosphorylation of Y951 leads to cell migration and actin stress fiber organization 
through interactions with T cell specific adaptor (TSAd) (Matsumoto et al., 2005). 
Phosphorylation of Y1214 is also implicated in actin stress fiber remodeling through the p38 
mitogen activated kinase pathway (Lamalice et al., 2004). Y951 and Y1175 are unique tyrosine 
residues in VEGFR2, whereas Y1214 is conserved in VEGFR2 and VEGFR3.  
 
 
Fig. 5. Signal transduction downstream of VEGFR2 
Y1173 in mouse VEGFR2 (corresponding to Y1175 in humans) is indispensable for blood 
vessel formation in vivo (Sakurai et al., 2005). VEGFR2 Y1173F knock-in mice died between 
E8.5 and E9.5, similar to VEGFR2-null mice. In Y1173F knock-in mice, VEGFR2+ vascular 
progenitor cells failed to migrate into the yolk sac to form blood islands, and, because 
vasculogenesis was aborted and progenitor cells did not receive specification signals, it 
remained unclear whether Y1173 is also important for endothelial specification of vascular 
progenitor cells. Therefore, we addressed this question using the in vitro differentiation 
system. 
3.2.3.1 Tyrosine 1175 of human VEGFR2 is required for endothelial differentiation 
To examine the roles of individual tyrosine residues in the induction of endothelial 
differentiation, we constructed three mutants of the R32 chimeric receptor (R32Y951F, 
R32Y1175F, and R32Y1214F) in which the indicated tyrosine residues were mutated to 
phenylalanine. After confirming the ability of these mutants to activate effective signals, we 
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established MGZRTcH ES cell lines expressing these mutant receptors (Tc-R32Y951F, Tc-
R32Y1175F, and Tc-R32Y1214F). VEGFR2+ vascular progenitor cells were prepared from 
these cell lines and examined for endothelial differentiation in the presence of VEGF-
C(C152S) (Sase et al., 2009).  
VEGFR2+ cells derived from Tc-R32Y951F and Tc-R32Y1214F differentiated into endothelial 
cells following treatment with VEGF-C(C152S) whereas those from Tc-R32Y1175F failed to 
do so. To exclude the possibility that signals associated with residues Y951 and Y1214 could 
compensate for one another to promote endothelial differentiation, we also established a cell 
line expressing a double mutant, Tc-R32Y951/1214F. VEGFR2+ cells derived from this cell 
line retained their ability to undergo endothelial differentiation. These findings indicate that 
signaling from Y1175 plays a central role in the endothelial differentiation of vascular 
progenitor cells, but residues Y951 and Y1214 are dispensable for this function.  
In this in vitro differentiation system, endothelial cells appear only when vascular progenitor 
cells are successfully specified into endothelial cells and when the differentiated endothelial 
cells are able to survive and proliferate (Fig. 6, top panel). Endothelial cells are unable to 
survive in the presence of serum alone, and they typically require growth factors such as 
VEGF-A or FGFs for survival and/or proliferation. We investigated whether signaling from 
Y1175 plays a role in specification, survival, or both processes. 
 
 
Fig. 6. VEGFR signaling and endothelial differentiation       
3.2.3.2 Tyrosine 1175 of human VEGFR2 is required for endothelial survival 
We first performed an endothelial survival assay (Fig. 7) with Tc-R32, Tc-R32Y1175F, and 
Tc-VEGFR3. ESC-derived VEGFR2+ cells were cultured with VEGF-A in serum-free medium 
for two days to induce mature endothelial cells, and the endothelial cells were then cultured 
in serum-free medium with or without VEGF-C(C152S) to activate the chimeric receptors.  
The number of endothelial cells cultured in the absence of VEGF-C(C152S) was considerably 
decreased within 12 h. VEGF-C(C152S)induced signaling from R32 led to a significant 
recovery in the number of cells, but VEGF-C(C152S) treatment of cells expressing R32Y1175 
failed to do so. Thus, Y1175 is involved in the transmission of survival signals to endothelial 
cells. As described in 3.2.1, VEGFR3 signaling is not sufficient for inducing endothelial 
differentiation from VEGFR2+ vascular progenitor cells. However, VEGFR3 signaling 
increased the survival of ESC-derived endothelial cells. We also found that LY294002, an 
inhibitor of PI3K, abrogated the effects of VEGFR3 on endothelial survival. These findings 
suggest that VEGFR3 signaling promotes endothelial survival despite its inability to direct 
endothelial specification (Fig. 6).  
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Fig. 7. Endothelial survival assay. When ESC-derived endothelial cells are cultured in 
serum-free medium, the cell number largely decreases within 12 h, while in the presence of 
an appropriate survival factor, the cell number is maintained.    
3.2.3.3 Tyrosine 1175 of human VEGFR2 is required for endothelial specification 
We next examined the involvement of signaling from Y1175 in the endothelial specification 
of vascular progenitor cells. Because R32Y1175F failed to transmit appropriate survival 
signals, we supplemented the cell cultures with a low dose of FGF-2 (0.5 ng/ml) to promote 
endothelial cell survival. VEGFR2+ cells derived from Tc-R32Y1175F failed to differentiate 
into endothelial cells upon stimulation with VEGF-C(C152S) although those derived from 
Tc-R32 successfully underwent differentiation. Thus, human VEGFR2 Y1175 is essential for 
the induction of endothelial cells from vascular progenitor cells through both specification 
of VEGFR2+ cells and their subsequent survival (Fig. 6). 
3.2.4 The VEGFR2-Y1175-PLC1 pathway is indispensable for endothelial 
specification 
In mature endothelial cells, Y1175 of human VEGFR2 primarily transmits cell proliferation 
signals through the recruitment of PLC and cell survival signals through the recruitment of 
Shb (Fig. 5). Intriguingly, PLC1 deficient mice are embryonically lethal secondary to a lack 
of vasculogenesis and erythrogenesis despite the presence of hemangioblasts (Liao et al., 
2002). Thus, PLC1 may be involved in the specification of vascular progenitor cells and/or 
subsequent survival of endothelial cells. We hypothesized that R32Y1175F failed to induce 
endothelial differentiation because it does not activate PLC1.  
3.2.4.1 Knockdown of PLC1 attenuated endothelial differentiation 
To elucidate the function of PLC1 in endothelial differentiation, we established a stable ES cell 
line in which expression of PLC1 can be knocked down by expression of pre-miRNA under 
the control of Tc (Tc-miRNA-PLC1) (Sase et al., 2009). We used this system to perform gene 
silencing studies because we had difficulty introducing siRNA oligonucleotides to VEGFR2+ 
vascular progenitor cells; we were able to easily introduce them into ES cells or differentiated 
endothelial cells, however (Kawasaki et al., 2008). It is likely that differentiating ES cells may 
be resistant to transfection at certain stages of development.   
Expression of the miRNA targeting PLC1 resulted in a modest decrease in PLC1 protein 
expression and decreased appearance of endothelial cells, indicating that PLC1 signaling is 
required for endothelial differentiation.  
3.2.4.2 Constitutively active PLC1 induces endothelial specification 
We next constructed a constitutively active form of PLC1, PalmPLC1, in which a sequence 
for myristoylation and palmitoylation was added to its N-terminus. This mutant protein is 
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constitutively localized at the plasma membrane. We then established a stable ES cell line 
harboring Tc-regulatable PalmPLC1 (Tc-PalmPLC1) or a negative control cell line (Tc-
empty) and examined the differentiation of VEGFR2+ cells derived from these cell lines.  
The induced expression of PalmPLC1 did not lead to the appearance of PECAM1+ cells 
from VEGFR2+ progenitor cells, and, after performing an endothelial survival assay, we 
found that PalmPLC1 did not transmit signals for cell survival in ESC-derived endothelial 
cells. We next examined endothelial differentiation of VEGFR2+ cells in the presence of a 
low dose of FGF-2 to support survival of endothelial cells. Stimulation with PalmPLC1 plus 
FGF-2 reconstituted signaling for endothelial differentiation although stimulation with only 
FGF-2 did not affect the number of differentiated endothelial cells. PalmPLC1-expressing 
progenitor cells treated with FGF-2 became positive for PECAM1, VE-cadherin, CD34, and 
endoglin, and these findings indicate that PLC1 signaling is involved in the endothelial 
specification of vascular progenitor cells but not in the survival of differentiated endothelial 
cells (Fig. 8). Consistent with this, VEGFR3, which transmits signals for endothelial survival 
but not endothelial specification, failed to activate PLC1 (Sase et al., 2009).  
At present, the signaling pathways downstream of Y1175 that mediate survival of 
endothelial cells remain to be elucidated. However, Shb may be a good candidate for a 
signaling effector because it activates the PI3K pathway. 
 
 
Fig. 8. Signaling from VEGFR2-Y1175 for induction of endothelial cells in vitro 
4. Ras signaling specifies endothelial lineage 
In addition to the chimeric receptor approach described above, we also used various 
pharmacological inhibitors to study endothelial differentiation (Kawasaki et al., 2008), and 
we found that temporally regulated Ras signaling plays a crucial role in endothelial 
specification downstream of PLC1. 
4.1 A farnesyltransferase inhibitor, FTI-277, inhibits VEGF-Ainduced endothelial 
differentiation of ESC-derived VEGFR2
+
 cells  
To determine the signaling components involved in VEGF-Ainduced endothelial 
differentiation from vascular progenitor cells, we screened various low molecular weight 
compounds targeting signaling molecules for their ability to inhibit endothelial 
differentiation in vitro. Among the compounds tested, we found that the farnesyltransferase 
inhibitor FTI-277 (Lerner et al., 1995) selectively affects endothelial differentiation. FTI-277 
interferes with the farnesylation of small G proteins and their subsequent association with 
the plasma membrane, thus abrogating their signaling functions. FTI-277 inhibited the 
appearance of VEGF-Ainduced PECAM1+ cells, but that of SMA+ was not. The effect of 
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FTI-277 was also confirmed in a limiting dilution assay. In the presence of FTI-277, the 
number of PECAM1+ colonies was decreased while SMA+ colonies were increased. 
Importantly, the total number of derived colonies was not significantly changed. These 
findings indicate that FTI-277 specifically inhibits the endothelial differentiation of ESC-
derived VEGFR2+ cells.  
We next performed an ex vivo whole-embryo culture assay to confirm the effects of FTI-277 
on vascular development in a mouse embryo (Fig. 9; Kawasaki et al., 2008). Concepti at 
embryonic day 6.75 (E 6.75) were picked out from the uteri of pregnant mice and cultured in 
vitro for three days, and, in the absence of further manipulation, PECAM1+ blood vessels 
formed in the yolk sac during this time. However, FTI-277 treatment led to a reduced 
number of PECAM1+ vessels, but the overall development of the yolk sac was not affected. 
Quantitative RT-PCR analysis also indicated that PECAM1 expression was decreased in the 
presence of FTI-277, while the expression of SMA was not affected. These findings suggest 
that FTI-277 selectively suppresses vascular development. Importantly, endothelial 
differentiation induced by constitutively active PalmPLC1 plus FGF-2 was inhibited by 
FTI-277, indicating that FTI-277 targets signaling pathway(s) downstream of PLC1.   
 
 
Fig. 9. FTI-277 inhibited ex vivo yolk sac vascularization (Kawasaki et al., 2008. Originally 
published in Journal of Cell Biology. doi: 10.1083/jcb.200709127). E6.75 concepti were picked 
out and cultured with or without FTI-277 (10 M) for three days and whole-mount stained 
for PECAM1. 
4.2 Loss of H-Ras attenuates endothelial differentiation of VEGFR2
+
 cells in vitro 
Because the principal targets of FTI-277 include H-Ras, we hypothesized that H-Ras 
signaling could be involved in the VEGF-Ainduced endothelial differentiation of vascular 
progenitor cells. To examine this possibility, we established an ES cell line based on 
MGZRTcH cells in which a pre-miRNA sequence targeting H-Ras is expressed under the 
control of Tc (Tc-miR-H-Ras). In Tc-miR-H-Ras cells, expression of endogenous H-Ras was 
efficiently knocked down in the absence of Tc (Tet-off system). A limiting dilution assay was 
performed using Tc-miR-H-Rasderived VEGFR2+ cells in the presence or absence of Tc. In 
the absence of Tc (H-Ras knocked-down condition), the number of VEGF-Ainduced 
PECAM1+ colonies was decreased while the number of SMA+ colonies was increased 
compared to cells grown in the presence of Tc (PECAM1:SMA=51.6%:48.4% to 
36.8%:63.2%). These findings suggest that H-Ras plays a role in the endothelial 
differentiation of VEGFR2+ progenitor cells.  
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4.3 Loss of H-Ras attenuates endothelial differentiation in mouse embryos  
To examine the importance of H-Ras signaling during vascular development in vivo, we 
investigated the vascular phenotype of H-ras knockout mice. Because heterozygous H-ras+/- 
mice produced homozygous H-ras/ offspring in the expected Mendelian ratio as 
previously reported (Ise et al., 2000), we focused on the vascular phenotype during early 
development. There were no clear differences in the vascular phenotypes of wild-type (WT) 
and H-ras+/- embryos. Vascular anomalies were found in the brain of 73% of H-ras-/- 
embryos examined at E9.5 although they contained similar numbers of somites as their WT 
littermates (Fig. 10; Kawasaki et al., 2008).  
We next double-stained the cephalic region of the embryos for PECAM1 and VEGFR2, the 
earliest marker of endothelial cell differentiation. In H-ras+/- embryos, numerous complex 
vascular networks were stained for both PECAM1 and VEGFR2, but vascular structures 
positive for either PECAM1 or VEGFR2 were strikingly reduced in H-ras-/- embryos. 
However, these defects were transient because no abnormalities were apparent in E10.5 H-
ras-/- embryos. Collectively, these data suggest that H-Ras signaling is involved in the in vivo 
differentiation of endothelial cells although it is not indispensable. 
 
 
Fig. 10. Whole-mount PECAM1 staining of E9.5 H-ras+/- and H-ras-/- mice (Kawasaki et al., 
2008. Originally published in Journal of Cell Biology. doi: 10.1083/jcb.200709127). 
Magnifications of the area marked with arrows in the top are shown in the bottom. 
4.4 A constitutively active G12V mutant of H-Ras induces PECAM1
+
 cells from 
VEGFR2
+
 progenitor cells 
We next established an ES cell line carrying a constitutively active form of H-Ras (Tc-H-
Ras[G12V]) under the control of Tc, and we examined the differentiation of VEGFR2+ cells 
derived from this cell line. When H-Ras[G12V] expression was suppressed by Tc treatment, 
the appearance of PECAM1+ cells was VEGF-Adependent. However, expression of H-
Ras[G12V] led to the VEGF-Aindependent induction of PECAM1+ cells. These PECAM1+ 
cells were also positive for other endothelial markers including CD34 and endoglin, and 
they incorporated AcLDL. Additionally, the aggregated VEGFR2+ cells derived from Tc-H-
Ras[G12V] cells formed tube-like structures even in the absence of VEGF-A when cultured 
in type I collagen gel for seven days, indicating that vascular formation by VEGFR2+ cells is 
dependent on H-Ras signaling. Furthermore, Tc-H-Ras[G12V] cells formed vascular 
structures when subcutaneously injected with Matrigel into the abdominal region of mice, 
dependent upon the expression of H-Ras[G12V]. These findings suggest that active Ras 
induces the differentiation of cells with characteristics of endothelial cells from VEGFR2+ 
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progenitor cells (Kawasaki et al., 2008). Additionally, data from a limiting dilution assay 
showed that expression of H-Ras[G12V] led to endothelial differentiation at the expense of 
mural differentiation. Thus, the fate of cell differentiation was altered by Ras signaling. 
Although Ras signaling induces the expression of VEGF-A (Rak et al., 1995; Gruger et al., 
1995), Ras-induced endothelial differentiation was not dependent on autocrine stimuation 
by induced VEGF-A.  Endothelial differentiation by H-Ras[G12V] proceeded normally in the 
presence of SU5614, an inhibitor of VEGFR2 kinase (Spiekermann et al., 2002), or VEGFR1 
(Flt1)-Fc chimeric protein which competes with VEGFR2 for binding to VEGF-A. 
Collectively, these findings suggest that differentiation depends on intracellular Ras 
signaling. 
4.5 Signaling for endothelial differentiation is mediated through the Ras-Erk pathway 
Ras proteins activate both the Raf/MEK/Erk and the PI3K/Akt pathways. To determine the 
signaling pathway(s) that mediate Ras-induced endothelial differentiation, we established 
ES cell lines in which H-Ras effector mutants H-Ras[G12V, T35S] or H-Ras[G12V, Y40C] can 
be inducibly expressed. The effector mutants H-Ras[G12V, T35S] and H-Ras[G12V, Y40C] 
preferentially activate the Raf/MEK/Erk and PI3K/Akt pathways, respectively (Joneson et 
al., 1996). When H-Ras[G12V, T35S] was expressed, PECAM1+ colonies increased in 
number, while SMA+ colonies were decreased as determined by limiting dilution assay. In 
contrast, when H-Ras[G12V, Y40C] was expressed, the numbers of PECAM1+ colonies and 
SMA+ colonies were unchanged. These findings suggest that the Ras-PI3K pathway does 
not affect the determination of cell fate, and we concluded that the Ras-Erk pathway 
specifies the endothelial fate of VEGFR2+ progenitor cells. 
4.6 Kinetics of Ras activation by VEGF-A 
Ras proteins are activated by extracellular stimuli including hormones, cytokines and 
growth factors. ESC-derived VEGFR2+ cells differentiate into endothelial cells upon 
stimulation with VEGF-A, but not upon stimulation with PDGF-BB, a known activator of 
Ras signaling. Thus, the activation statuses of Ras are different between that downsteam of 
VEGFR2 and that downstream of PDGF receptors.  
We examined the effects of FTI-277 treatment at different time points after VEGF-A 
stimulation. FTI-277 inhibited endothelial differentiation even when added 3 h after VEGF-
A stimulation, indicating that Ras activation later than 3 h after stimulation plays a role in 
endothelial differentiation. We hypothesized that the specificity of Ras signaling induced by 
VEGFR2 may be attributed to the timing of Ras activation, and we investigated the window 
within which Ras is specifically activated by VEGF-A, focusing on the period later than 3 h 
after VEGF-A stimulation.  
We examined the levels of phosphorylation of Erk, a downstream effector of Ras, 312 h 
after stimulation with VEGF-A. Erk phosphorylation peaked at 6 h and 9 h after stimulation, 
suggesting that Ras could be activated with a similar time course. We next examined the 
activation of Ras in cells stimulated with VEGF-A or PDGF-BB for 6 h, and the patterns of 
Ras activation in response to VEGF-A or PDGF-BB were markedly different. At 6 h after 
stimulation, VEGF-A caused intense activation of Ras and Erk, whereas PDGF-BB failed to 
activate both Ras and Erk. At 5 min after stimulation, both VEGF-A and PDGF-BB induced 
activation of Ras and Erk although to different extents. Activation of Ras and Erk by VEGF-
A was also observed at 9 h, but not at 3 h after stimulation (Fig. 11). Importantly, 
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phosphorylation of Erk around 6 h after VEGF-A stimulation was sensitive to FTI-277. 
Activation of the Ras-Erk pathway 69 h after stimulation with VEGF-A thus appears to 
direct endothelial differentiation of VEGFR2+ progenitor cells. These findings provide 
mechanistic insights into signaling events required for cell specification through widely-
shared effector molecules. 
4.7 VEGF-Aspecific Ras activation precedes the expression of endothelial markers 
We finally examined whether the expression of vascular markers is induced after the 
delayed activation of the Ras-Erk pathway during in vitro differentiation of vascular 
progenitor cells. The mRNA expression of the endothelial markers PECAM1 and VE-
cadherin increased from 12 h after VEGF-A stimulation. Intriguingly, the expression of 
VEGFR2 in VEGF-Astimulated cells was similar to that seen in non-stimulated cells up to 6 
h after treatment. However, at time points later than 12 h after stimulation, VEGFR2 
expression was up-regulated in VEGF-Astimulated cells, but it was down-regulated in 
non-stimulated cells. These observations suggest that specification to endothelial lineage 
occurs between 612 h after stimulation with VEGF-A, and this is preceded by the delayed 
activation of Ras (Fig. 11). We conclude that VEGF-A stimulation of VEGFR2+ vascular 
progenitor cells specifically induces Ras-Erk activation around 69 h after stimulation, and 
this event in turn specifies endothelial differentiation.  
 
 
Fig. 11. Kinetics of endothelial differentiation of vascular progenitor cells after VEGF-A 
stimulation. The link between PLC and Ras-Erk (the second double-headed arrow) remains 
to be elucidated. 
5. Unsolved questions in signaling for endothelial differentiation  
The development of multicellular organisms requires the orchestrated interactions of a wide 
variety of cells, including growth, migration, and differentiation. Extracellular factors as 
well as intracellular signaling molecules are involved in the regulation of cellular processes 
during development. Each signaling molecule appears to have defined functions that are 
dependent upon the appropriate cellular context. 
VEGFR2 signaling plays a central role in de novo blood vessel formation. In an in vitro 
embryoid body culture system, VEGFR2-/- ES cells still give rise to endothelial cells with low 
efficiency (Schuh et al., 1999). This may be due to an effects of FGF-2 included in the culture 
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medium (Schuh et al., 1999), because FGF-2 induces endothelial differentiation of ESC-
derived VEGFR2+ cells to a modest extent (Kano et al., 2005). VEGFR2 signaling appears to 
be the primary pathway for controlling endothelial specification with high efficiency, 
although it is not the sole pathway capable of mediating these effects. We found that 
activation of the Ras-Erk pathway 69 h after stimulation with VEGF-A plays a critical role 
in endothelial specification of vascular progenitor cells. The mechanism(s) regulating the 
delayed activation of Ras and the downstream signaling of the Ras-Erk pathway are the next 
questions to be solved.  
5.1 Upstream and downstream of the delayed Ras activation induced by VEGF-A   
In ESC-derived VEGFR2+ progenitor cells, the PKC-dependent pathway (Fig. 5) appears to 
be activated early, since phosphorylation of Erk was notably increased while activation of 
Ras was modest 5 min after VEGF-A stimulation (Kawasaki et al., 2008). In contrast, the Ras 
pathway strongly induced Erk phosphorylation 69 h after stimulation, a finding supported 
by the inhibition of Erk phosphorylation by FTI-277. The mechanism(s) controlling the 
delayed activation of Ras remain unclear. At present, we only know that PLC1 lies 
upstream of the delayed Ras activation. It is possible that Ras activation is mediated through 
the transcriptional induction of some signaling molecules and/or activation of other 
signaling receptor(s). It is also important to identify transcription factors that are 
phosphorylated by Erk to better understand the signaling specificity of early and late Erk 
activation. VEGFR2+ cells develop into mural cells in the absence of growth factor, and 
mural differentiation may be the default fate of VEGFR2+ cells. During the differentiation of 
vascular progenitor cells, induction of mural markers is delayed compared to the induction 
of endothelial markers by VEGF-A: expression of SMA was increased at 24 h while 
PECAM1 became expressed from 12 h after stimulation. It appears likely that VEGFR2+ cells 
in which the delayed Ras-Erk signaling is activated before the determination of cell fate to 
mural cells are differentiated into endothelial cells. However, it remains possible that VEGF-
A signaling merely suppresses mural differentiation, thus altering the default differentiation 
fate. Alternatively, it is possible that VEGF-A signaling not only induces endothelial 
differentiation but also suppresses mural differentiation. 
Although Ras appears to be activated downstream of PLC1 in vascular progenitor cells 
after stimulation with VEGF-A, constitutively active Ras transmits sufficient signals for full 
endothelial differentiation while constitutively active PLC1 transmits signals only for 
endothelial specification. This discrepancy remains unexplored. It is likely that 
constitutively active effector molecules may transmit artificial signals. In particular, G12V 
mutants of Ras proteins are resistant to intrinsic negative regulation through hydrolysis of 
GTP. H-Ras[G12V] may constitutively send strong signals that are sufficient to fully induce 
endothelial differentiation.   
5.2 Phenotypes of H-Ras knockout mice 
We examined vascular formation in H-ras-/- mice, and vascular anomalies were found in the 
brain of 73% of E9.5 H-ras-/- embryos. However, there were no obvious abnormalities in 
E10.5 H-ras-/- embryos, consistent with the previous report that H-ras knockout mice are 
born and grow normally (Ise et al., 2000). These findings suggest that H-ras-/- embryos catch 
up for the delay in vascular formation in the cephalic region until E10.5. It is possible that 
expression of other Ras family members, N-Ras and K-Ras, is upregulated, and these 
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proteins may compensate for the loss of H-Ras (Ise et al., 2000). Alternatively, a reduction of 
endothelial differentiation in the absence of H-Ras may be permissive for embryonic 
development. Compensatory growth of differentiated endothelial cells may offset the 
reduction in endothelial differentiation. It appears likely that N-Ras and K-Ras are also 
involved in endothelial specification because treatment with FTI-277 or knockdown of H-
Ras failed to completely inhibit endothelial specification induced by VEGF-A in the in vitro 
vascular differentiation system.  
5.3 Towards more efficient differentiation of endothelial cells 
In recent years, revascularization therapy using endothelial progenitor cells (EPCs) has been 
studied for the treatment of ischemic disorders and arteriosclerosis. In this therapy, EPCs 
implanted at sites of disease form new vascular structures. Identification of the signaling 
pathways required for endothelial differentiation could provide valuable information for 
establishing a highly efficient endothelial differentiation system. This would be a boon to 
the field of regenerative medicine. 
The efficiency of endothelial differentiation of vascular progenitor cells in vitro remains ~50%. 
Differentiating ES cells actively proliferate, indicating that they are going through cell cycles. 
Recent work revealed that Ras can efficiently transmit signals during G1 phase but not during 
G1/S or S/G2 (SakaueSawano et al., 2008). Signals for endothelial specification are likely 
successfully transmitted in vascular progenitor cells at G1 phase (Fig. 12). Manipulations that 
control the cell cycle status may improve the efficiency of specification of vascular progenitor 
cells to endothelial cells, which is transmitted principally through Ras proteins. 
 
 
Fig. 12. Possible cell cycledependent signaling for endothelial differentiation through Ras 
activation 
Modulation of the VEGFR2 signaling pathway at the level of receptorligand interaction 
may also improve the efficiency of endothelial differentiation in vitro. Recently, protein 
kinase A was found to induce expression of VEGFR2 and its co-receptor neuropilin-1, thus 
enhancing vascular progenitor potential (Yamamizu et al., 2009). 
6. Conclusions 
Vascular endothelial growth factor 2 (VEGFR2) is a critical signaling component controlling 
many aspects of vasculogenesis during embryonic development, including proliferation, 
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migration, and endothelial differentiation of vascular progenitor cells. However, the 
signaling pathways specifying endothelial differentiation downstream of VEGFR2 are 
poorly understood. We investigated these signaling pathways using an in vitro endothelial 
differentiation system (Kawasaki et al., 2008; Sase et al., 2009). Using a variety of different 
approaches including chimeric receptors, gene silencing, gain-of-function mutants, and 
pharmacological inhibitors, we dissected the signal transduction pathway that directs 
endothelial differentiation (Fig. 13). In response to VEGF-A stimulation, VEGFR2 transmits 
signals for specification of vascular progenitor cells and survival of endothelial cells through 
Y1175. PLC1, a downstream effector that is recruited to phosphorylated Y1175, relays 
endothelial specification signals. Activation of H-Ras that occurs at a delayed phase after 
VEGF-A stimulation triggers endothelial specification. The unique activation of signaling 
molecules downstream of VEGFR2/PLC/Ras is essential for transmitting signals 
controlling endothelial specification. At the present time, the link between PLC1 and H-Ras 
remains to be identified. Shb, another downstream effector recruited to phosphorylated 
Y1175, may be involved in the survival of endothelial cells through activation of the PI3K 
pathway. VEGFR3 lacks the ability to induce endothelial specification, and this may be due 
to its inability to activate PLC1, although it activates the PI3K pathway to support 
endothelial cell survival. It has previously been shown that Y1175 signaling is indispensable 
for migration of vascular progenitor cells to the site of their differentiation (Sakurai et al., 
2005). Therefore, Y1175 of VEGFR2 appears to be a central node transmitting signals 
required for endothelial differentiation including migration, specification, and subsequent 
cell survival.  
 
 
Fig. 13. Signal transduction pathways for endothelial differentiation from VEGFR2 
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